Efficacy of a Web-based Tailored Weight Management Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00284167|
Recruitment Status : Completed
First Posted : January 31, 2006
Last Update Posted : July 27, 2011
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Behavioral: tailored web-based weight management intervention||Phase 2 Phase 3|
This will be a randomized control, web-based trial for weight management with four treatment arms. Participants will be assigned to receive tailored materials from either: 1) the Balance program, 2) the Balance and Nourish programs, 3) the Balance and Achieve programs, or 4) the Balance, Nourish and Achieve programs. Participants will be recruited directly through their health care organization. In order to participate, participants must visit the website to confirm their eligibility, e.g. valid e-mail address. Those who wish to participate will provide consent on the Web, and then will be presented with an online questionnaire. These questions will provide baseline data for each participant and will be the basis for the tailoring of the Balance materials each participant will receive. Within 24 hours of submitting the completed questionnaire, participants will be informed by e-mail that their tailored Balance plan is available on the website. They will receive follow-up materials by e-mail during the six-week period after they enroll. Participants who have been assigned to additional programs will be sent e-mails with links to the relevant programs. At 3, 12 and 18 months, all participants will be assessed via an online survey. The assessment will include weight management parameters, psychosocial outcomes, and program utilization. This data will be self-reported.
STUDY POPULATION The study sample will be drawn from members of three integrated delivery systems: Kaiser Permanente Colorado (KPCO), Kaiser Permanente Ohio (KPOH), and Group Health Cooperative (GHC) of Puget Sound. In order to participate, participants must access and enroll in the study on the Web. A total of 1,848 participants will be enrolled within a six-month period, with approximately 450 participants in each treatment arm. By 18-month follow-up, we assume successful data collection from at least 65 percent of the enrollees, or 1200 participants, 300 in each treatment group. The study is open to those who meet the inclusion and exclusion criteria.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1848 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||Efficacy of a Web-based Tailored Weight Management Program With and Without Tailored Nutrition and Goal Setting Support|
|Study Start Date :||September 2003|
|Study Completion Date :||July 2006|
- The primary objective of this study is to assess weight reduction at 3, 12, and 18 months post intervention.
- • To assess psychosocial outcomes including motivation and self-efficacy.
- • To assess the degree to which participants perceive their support materials have been tailored for them.
- • To assess lifestyle changes including physical activity and nutrition
- • To examine relative effectiveness of web-based programs given age, gender, preferred language, ethnicity, and utilization patterns.
- • To examine percent of weight loss goal attainment.
- • To examine participation rates by the BMI strata stated above.
- • To assess the perceived helpfulness of the behavioral support materials with the participants' weight loss attempts.
- • To assess the overall satisfaction with the programs.
- • To assess participant satisfaction with Kaiser Permanente or GHC.
- • To assess changes in self-reported health status.
- • To assess changes in self-reported medical outpatient utilization.
- • To assess self-reported work productivity (days missed from work or school).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284167
|United States, California|
|Kaiser Permanente Care Management Institute|
|Walnut Creek, California, United States, 94596|
|Principal Investigator:||Kevin J Wildenhaus, Ph.D.||HealthMedia, Inc.|
|Principal Investigator:||Russ Glasgow, Ph.D.||Kaiser Permanente|